Use of a polypeptide having the activity of the human interleukin 2 to the to prepare a pharmaceutical composition destiny to the treatment of malignant epithelial.

摘要

PCT No. PCT/FR90/00951 Sec. 371 Date Jul. 8, 1992 Sec. 102(e) Date Jul. 8, 1992 PCT Filed Dec. 27, 1990 PCT Pub. No. WO92/07577 PCT Pub. Date May 14, 1992.The use of a polypeptide having human interleukin 2 activity for preparing a pharmaceutical composition for treating malignant epithelial tumours of the upper respiratory/alimentary tract or the thymus, is described.